Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product ...

Vistagen (VTGN) presented exploratory data at The Menopause Society 2025 annual meeting in Orlando, Florida. These findings demonstrate PH80’s potential as a rapidly-acting pherine product candidate ...

Receptor patterns define key organizational principles in the brain, scientists have discovered. An international team of researchers, studying macaque brains, have mapped out neurotransmitter ...

Though Aβ tends to hog the research spotlight, scientists have steadily built a case for the importance of another APP fragment—secreted APP. Now, a paper in the January 11 Science explains how it ...

Psychedelics are now a rapidly growing area of neuroscience and clinical research, one that may produce much-needed new therapies for disorders such as depression and schizophrenia. Yet there is still ...

Receptor patterns define key organizational principles in the brain, scientists have discovered. Receptor patterns define key organisational principles in the brain, scientists have discovered. An ...

In the world's largest study on psychedelics and the brain, a team of researchers have shown how drug-induced changes in subjective awareness are anatomically rooted in specific neurotransmitter ...

Researchers at Karolinska Institutet, Columbia University and the University of San Francisco, have uncovered a previously ...

Researchers are one step closer to understanding why some babies are at greater risk of sudden infant death syndrome, or SIDS – the leading cause of death for infants 1 month to 1 year old. Most of ...